Tackling the emerging threat of antifungal resistance to human health
© 2022. Springer Nature Limited..
Invasive fungal infections pose an important threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a period of profound global environmental change and expanding at-risk populations, human-infecting pathogenic fungi are evolving resistance to all licensed systemic antifungal drugs. In this Review, we highlight the main mechanisms of antifungal resistance and explore the similarities and differences between bacterial and fungal resistance to antimicrobial control. We discuss the research and innovation topics that are needed for risk reduction strategies aimed at minimizing the emergence of resistance in pathogenic fungi. These topics include links between the environment and One Health, surveillance, diagnostics, routes of transmission, novel therapeutics and methods to mitigate hotspots for fungal adaptation. We emphasize the global efforts required to steward our existing antifungal armamentarium, and to direct the research and development of future therapies and interventions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Nature reviews. Microbiology - 20(2022), 9 vom: 28. Sept., Seite 557-571 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fisher, Matthew C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 16.08.2022 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41579-022-00720-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338821139 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338821139 | ||
| 003 | DE-627 | ||
| 005 | 20240320232721.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41579-022-00720-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM338821139 | ||
| 035 | |a (NLM)35352028 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fisher, Matthew C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tackling the emerging threat of antifungal resistance to human health |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.08.2022 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. Springer Nature Limited. | ||
| 520 | |a Invasive fungal infections pose an important threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a period of profound global environmental change and expanding at-risk populations, human-infecting pathogenic fungi are evolving resistance to all licensed systemic antifungal drugs. In this Review, we highlight the main mechanisms of antifungal resistance and explore the similarities and differences between bacterial and fungal resistance to antimicrobial control. We discuss the research and innovation topics that are needed for risk reduction strategies aimed at minimizing the emergence of resistance in pathogenic fungi. These topics include links between the environment and One Health, surveillance, diagnostics, routes of transmission, novel therapeutics and methods to mitigate hotspots for fungal adaptation. We emphasize the global efforts required to steward our existing antifungal armamentarium, and to direct the research and development of future therapies and interventions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Antifungal Agents |2 NLM | |
| 700 | 1 | |a Alastruey-Izquierdo, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Berman, Judith |e verfasserin |4 aut | |
| 700 | 1 | |a Bicanic, Tihana |e verfasserin |4 aut | |
| 700 | 1 | |a Bignell, Elaine M |e verfasserin |4 aut | |
| 700 | 1 | |a Bowyer, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Bromley, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Brüggemann, Roger |e verfasserin |4 aut | |
| 700 | 1 | |a Garber, Gary |e verfasserin |4 aut | |
| 700 | 1 | |a Cornely, Oliver A |e verfasserin |4 aut | |
| 700 | 1 | |a Gurr, Sarah J |e verfasserin |4 aut | |
| 700 | 1 | |a Harrison, Thomas S |e verfasserin |4 aut | |
| 700 | 1 | |a Kuijper, Ed |e verfasserin |4 aut | |
| 700 | 1 | |a Rhodes, Johanna |e verfasserin |4 aut | |
| 700 | 1 | |a Sheppard, Donald C |e verfasserin |4 aut | |
| 700 | 1 | |a Warris, Adilia |e verfasserin |4 aut | |
| 700 | 1 | |a White, P Lewis |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Jianping |e verfasserin |4 aut | |
| 700 | 1 | |a Zwaan, Bas |e verfasserin |4 aut | |
| 700 | 1 | |a Verweij, Paul E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Microbiology |d 2003 |g 20(2022), 9 vom: 28. Sept., Seite 557-571 |w (DE-627)NLM147304695 |x 1740-1534 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |g number:9 |g day:28 |g month:09 |g pages:557-571 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41579-022-00720-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 |e 9 |b 28 |c 09 |h 557-571 | ||